Xylem (NYSE:XYL) PT Lowered to $110.00

Xylem (NYSE:XYLGet Rating) had its target price cut by equities researchers at Morgan Stanley from $120.00 to $110.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the industrial products company’s stock. Morgan Stanley’s price objective suggests a potential upside of 31.33% from the company’s current price.

Other equities analysts have also issued reports about the stock. Zacks Investment Research upgraded shares of Xylem from a “strong sell” rating to a “hold” rating and set a $92.00 price target on the stock in a research report on Wednesday, April 6th. StockNews.com assumed coverage on shares of Xylem in a research report on Thursday, March 31st. They set a “hold” rating on the stock. Raymond James upgraded shares of Xylem from an “underperform” rating to a “market perform” rating in a research report on Tuesday, April 5th. Stifel Nicolaus decreased their target price on shares of Xylem from $100.00 to $90.00 in a report on Monday. Finally, Credit Suisse Group decreased their target price on shares of Xylem from $111.00 to $98.00 and set an “underperform” rating on the stock in a report on Friday, February 4th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, Xylem has a consensus rating of “Hold” and an average target price of $114.45.

XYL traded down $0.38 on Monday, reaching $83.76. The stock had a trading volume of 2,360 shares, compared to its average volume of 1,472,706. The company has a market cap of $15.08 billion, a P/E ratio of 35.64, a price-to-earnings-growth ratio of 2.72 and a beta of 1.11. The business’s 50-day moving average price is $87.49 and its two-hundred day moving average price is $108.18. The company has a current ratio of 2.27, a quick ratio of 1.77 and a debt-to-equity ratio of 0.76. Xylem has a 12-month low of $82.03 and a 12-month high of $138.78.

Xylem (NYSE:XYLGet Rating) last released its earnings results on Thursday, February 3rd. The industrial products company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.01. The business had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.31 billion. Xylem had a net margin of 8.22% and a return on equity of 14.67%. The company’s quarterly revenue was down 3.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.81 earnings per share. As a group, analysts predict that Xylem will post 2.57 earnings per share for the current year.

Hedge funds have recently modified their holdings of the company. James Reed Financial Services Inc. acquired a new position in shares of Xylem in the 4th quarter worth approximately $26,000. AGF Investments LLC acquired a new position in shares of Xylem in the 4th quarter worth approximately $27,000. UMB Bank N A MO acquired a new position in shares of Xylem in the 4th quarter worth approximately $27,000. Moors & Cabot Inc. increased its stake in Xylem by 309.6% during the 3rd quarter. Moors & Cabot Inc. now owns 28,000 shares of the industrial products company’s stock worth $28,000 after buying an additional 21,164 shares during the period. Finally, Bell Investment Advisors Inc purchased a new stake in Xylem during the 3rd quarter worth approximately $32,000. Hedge funds and other institutional investors own 83.99% of the company’s stock.

About Xylem (Get Rating)

Xylem, Inc engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water.

Featured Articles

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.